| Literature DB >> 30847380 |
Yuri Kinoshita1, Takeshi Kono1, Shin-Ichi Ansai2, Hidehisa Saeki3.
Abstract
Entities:
Keywords: EPF, eosinophilic pustular folliculitis; aggressive; eosinophilic pustular folliculitis; face; granulomatous; indomethacin
Year: 2019 PMID: 30847380 PMCID: PMC6389553 DOI: 10.1016/j.jdcr.2019.01.002
Source DB: PubMed Journal: JAAD Case Rep ISSN: 2352-5126
Fig 1A-C, Eosinophilic pustular folliculitis: clinical features of the lesion. (A and B) At the initial presentation, well-defined erythematous, indurated plaques involving the nose, forehead (A), and the cheeks bilaterally (B) were seen. C, The plaques had numerous pustules and crusts. D and E, Eosinophilic pustular folliculitis: histopathologic features of the initial biopsy. D, Epidermis is intact, and dense infiltration of inflammatory cells within and around the follicules can be seen. E, Inflammatory cells are composed of lymphocytes, histiocytes and eosinophils. (D and E, Hematoxylin-eosin stain)
Fig 2A-C, Eosinophilic pustular folliculitis: clinical features of the lesion after 4 weeks. A and B, After 4 weeks of treatment with oral indomethacin (75 mg/d), along with oral tetracycline and topical corticosteroids, there was only residual pigmentation on the forehead (A) and cheeks (B). C, There was no longer induration, pustules, or crust.